tenk.fyi

NOVAVAX INC

NVAXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.1B

64.7% YoY

Net Income

$440.3M

334.8% YoY

EPS

$2.58

309.8% YoY

Cash

$240.6M

54.6% YoY

FY 2025 · As of 2025-12-31